Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain.
D000577:Amides / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D002250:Carbon Radioisotopes; D002395:Catecholamines / Q000378:metabolism*; D002552:Cerebral Ventricles; D004221:Disulfiram / Q000494:pharmacology; D004298:Dopamine / Q000008:administration & dosage / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D004305:Dose-Response Relationship, Drug; D000431:Ethanol / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007211:Indoles / Q000378:metabolism / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010293:Pargyline / Q000494:pharmacology; D010848:Picolinic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D013268:Stimulation, Chemical; D013844:Thiazoles / Q000494:pharmacology; D013890:Thiourea / Q000031:analogs & derivatives / Q000494:pharmacology
D000577:Amides; D002250:Carbon Radioisotopes; D002395:Catecholamines; D007211:Indoles; D010848:Picolinic Acids; D013844:Thiazoles; D012701:Serotonin; D000431:Ethanol; D006897:Hydroxyindoleacetic Acid; D010293:Pargyline; D004299:Dopamine beta-Hydroxylase; D013890:Thiourea; D004221:Disulfiram; D004298:Dopamine